Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female Adolescents
Tóm tắt
The purpose of this study is to assess awareness, knowledge and beliefs about HPV, cervical cancer HPV vaccine and willingness to vaccinate among adolescent females aged 12–26 years at clinics and schools in the North West Region of Cameroon where the Cameroon Baptist Convention Health Services (CBCHS) conducted a sensitization and education campaign. A questionnaire survey was administered among female adolescents in schools and clinics. Descriptive statistics including frequencies, percentages and proportions were generated for independent variables and bivariate analyses (Chi square test) were used to assess the relationship between independent and outcome variables. Data were analyzed using SAS Version 9.2. Out of a sample of 650 adolescent girls 553 willingly participated in this anonymous survey. Awareness of HPV (86.8%), cervical cancer (82.3%), and prevention of HPV infections through vaccination (75.9%) was significantly higher than in previous studies conducted in Cameroon and other developing countries. Higher perceptions of risk were associated with being sexually active (p = 0.0013), age (p = 0.0031) and level of education (p = 0.0274). Age and educational level were associated with HPV knowledge (p = 0.007 and p = 0.0008), respectively. The mean level of interest in HPV vaccination was 4.0 (SD = 1.27), which is above the mean. Our data indicate high awareness about HPV, cervical cancer and HPV vaccine among adolescents, and interest in receiving the vaccine and learning about the disease. CBCHS’ community education strategy effectively raised acceptability and generated demand for HPV vaccine, making it a potential model for HPV immunization in Cameroon and other developing countries.
Tài liệu tham khảo
Anorlu, R. I. (2008). Cervical cancer: The sub-Saharan African perspective. Reprod Health Matters, 16(32), 41–49.
Parkin, D. M., Ferlay, J., Hamdi-Cherif, M., Sitas, F., Thomas, J., Wabinga, H, et al. (2003). Cancer in Africa: Epidemiology and prevention. IARC Press (IARC Scientific Publication No. 153).
Denny, L. (2005). The prevention of cervical cancer in developing countries. BJOG, 112(9), 1204–1212.
Farmer, P., Frenk, J., Knaul, F. M., Shulman, L. N., Alleyne, G., Armstrong, L., et al. (2010). Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet, 376(9747), 1186–1193.
Agosti, J. M., & Goldie, S. J. (2007). Introducing HPV vaccine in developing countries–key challenges and issues. New England Journal of Medicine, 356(19), 1908–1910.
WHO. (2010). WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Cameroon. Summary Report 2010. www.who.int/hpvcentre. Accessed 28 Aug 2011.
World Health Organization. (2002). Cervical cancer screening in developing countries: Report of a WHO consultation. Geneva: World Health Organization.
Durst, M., Gissmann, L., Ikenberg, H., & Zur Hausen, H. (1983). A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences, 80(12), 3812.
WHO. (2009). Human papillomavirus vaccines: WHO position paper. WHO Weekly epidemiological record, 84(15), 117–132.
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., et al. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine, 356(19), 1928–1943.
Tan, J., Farrell, L., & Allen, D. G. (2010). The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey. Australian and New Zealand Journal of Obstetrics and Gynaecology, 50(5), 472–477.
Cutts, F. T., Franceschi, S., Goldie, S., Castellsague, X., de Sanjose, S., Garnett, G., et al. (2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization, 85(9), 719–726.
Munoz, N., Bosch, F. X., Castellsague, X., Diaz, M., de Sanjose, S., Hammouda, D., et al. (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer, 111(2), 278–285.
Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahe, C., et al. (2005). Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine, 353(20), 2158–2168.
Wright, T. C, Jr, Denny, L., Kuhn, L., Pollack, A., & Lorincz, A. (2000). HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA, 283(1), 81–86.
Doh, A. S., Nkele, N. N., Achu, P., Essimbi, F., Essame, O., & Nkegoum, B. (2005). Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. International Journal of Gynaecology and Obstetrics, 89(2), 167–173.
Denny, L., Quinn, M., & Sankaranarayanan, R. (2006). Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24(Suppl 3), S3/71–S3/77.
Mbakop, A., Yomi, J., Yankeum, J., & Nkegoum, B. (1997). Mouelle Sone A: [Cancer localisation in men and women aged over 50 in Cameroon]. Bulletin du Cancer, 84(12), 1119–1122.
Tebeu, P. M., Major, A. L., Rapiti, E., Petignat, P., Bouchardy, C., Sando, Z., et al. (2008). The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. International Journal of Gynecological Cancer, 18(4), 761–765.
Atashili, J., Smith, J. S., Adimora, A. A., Eron, J., Miller, W. C., & Myers, E. (2011). Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: A simulation. PLoS ONE, 6(4), e18527.
De Vuyst, H., Lillo, F., Broutet, N., & Smith, J. S. (2008). HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. European Journal of Cancer Prevention, 17(6), 545–554.
Hawes, S. E., Critchlow, C. W., Sow, P. S., Toure, P., N’Doye, I., Diop, A., et al. (2006). Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. Journal of the National Cancer Institute, 98(2), 100–109.
Massad, L. S., Ahdieh, L., Benning, L., Minkoff, H., Greenblatt, R. M., Watts, H., et al. (2001). Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 27(5), 432–442.
Mogtomo, M. L., Malieugoue, L. C., Djiepgang, C., Wankam, M., Moune, A., & Ngane, A. N. (2009). Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer, 4, 9.
Schuman, P., Ohmit, S. E., Klein, R. S., Duerr, A., Cu-Uvin, S., Jamieson, D. J., et al. (2003). Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Journal of Infectious Diseases, 188(1), 128–136.
McCarey, C., Pirek, D., Tebeu, P. M., Boulvain, M., Doh, A. S., & Petignat, P. (2011). Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Women’s Health, 11(1), 45.
Wamai, R., Ayissi, C. A., Oduwo, G. O., Perlman, S. M., Welty, E., Manga, S., et al. (2012). Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. Journal of Community Health [Epub ahead of print].
World Health Organization. (2006). Promotion RHWHOCDH: Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO.
Likert, R. (1932). A technique for the measurement of attitudes. Archives of psychology, 22(140), 1–55.
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., et al. (2009). HPV screening for cervical cancer in rural India. New England Journal of Medicine, 360(14), 1385–1394.
Parham, G. P., & Mwanahammuntu, M. (2004). Building a cervical cancer prevention program into the HIV care and treatment infrastructure in Zambia. From the Ground Up, 2, 429–445.
Parham, G. P., Mwanahamuntu, M. H., Sahasrabuddhe, V. V., Westfall, A. O., King, K. E., Chibwesha, C., et al. (2010). Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Therapy, 4(6), 713–722.
Cremer, M., Jamshidi, R., Muderspach, L., Tsao-Wei, D., Felix, J., & Blumenthal, P. (2005). Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. International Journal of Gynecology & Obstetrics, 91(1), 42–46.
Blumenthal, P. D., Gaffikin, L., Deganus, S., Lewis, R., Emerson, M., & Adadevoh, S. (2007). Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. American Journal of Obstetrics and Gynecology, 196(4):407 e401–408; discussion 407 e408-409.
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008). Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med, 5(6), e132.
Mwanahamuntu, M. H., Sahasrabuddhe, V. V., & Parham, G. P. (2009). HPV screening for cervical cancer in rural India. The New England Journal of Medicine, 361(3):305; author reply 306.
Becker-Dreps, S., Otieno, W. A., Brewer, N. T., Agot, K., & Smith, J. S. (2010). HPV vaccine acceptability among Kenyan women. Vaccine, 28(31), 4864–4867.
DiAngi, Y. T., Panozzo, C. A., Ramogola-Masire, D., Steenhoff, A. P., & Brewer, N. T. (2011). A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana. PLoS ONE, 6(10), e25481.
Iliyasu, Z., Abubakar, I., Aliyu, M., & Galadanci, H. (2010). Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. Journal of Obstetrics and Gynaecology, 30(8), 857–862.
Coleman, M. A., Levison, J., & Sangi-Haghpeykar, H. (2011). HPV vaccine acceptability in Ghana, West Africa. Vaccine, 29(23), 3945–3950.
Francis, S. A., Nelson, J., Liverpool, J., Soogun, S., Mofammere, N., & Thorpe, R. J, Jr. (2010). Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine, 28(50), 8026–8032.
Katahoire, R., Jitta, J., Kivumbi, G., Murokora, D., Arube, W. J., Siu, G., et al. (2010) An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health, 12(3).
Mupepi, S. C., Sampselle, C. M., & Johnson, T. R. B. (2011). Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. Journal of Women’s Health, 20(6), 943–952.
Cremer, M. L., Conlisk, E., & Felix, J. C. (2009) HPV screening for cervical cancer in rural India. The New England journal of medicine, 361(3):305; author reply 306.
Dell, D. L., Chen, H., Ahmad, F., & Stewart, D. E. (2009) Knowledge about human papillomavirus among adolescents. Obstetrics & gynecology, 96(5, Part 1):653.
Woodhall, S. C., Lehtinen, M., Verho, T., Huhtala, H., Hokkanen, M., & Kosunen, E. (2007). Anticipated acceptance of HPV vaccination at the baseline of implementation: A survey of parental and adolescent knowledge and attitudes in Finland. Journal of Adolescent Health, 40(5), 466–469.
Di Giuseppe, G., Abbate, R., Liguori, G., Albano, L., & Angelillo, I. (2008). Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. British Journal of Cancer, 99(2), 225–229.
Blumenthal, J., Frey, M. K., Worley, M. J., Tchabo, N. E., Soren, K., & Slomovitz, B. M. (2012). Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City. Journal of Oncology. doi:10.1155/2012/904034.
Gellin, B. G., Maibach, E. W., & Marcuse, E. K. (2000). Do parents understand immunizations? A national telephone survey. Pediatrics, 106(5), 1097–1102.
Jakeway, C. C., LaRosa, G., Cary, A., & Schoenfisch, S. (2008). The role of public health nurses in emergency preparedness and response: A position paper of the association of state and territorial directors of nursing. Public Health Nursing, 25(4), 353–361.
Lindley, M. C., Boyer-Chu, L., Fishbein, D. B., Kolasa, M., Middleman, A. B., Wilson, T., et al. (2008). The role of schools in strengthening delivery of new adolescent vaccinations. Pediatrics, 121(Suppl 1), S46–S54.
Nkowane, A. M., Boualam, L., Haithami, S., El Sayed el, T. A., & Mutambo, H. (2009). The role of nurses and midwives in polio eradication and measles control activities: a survey in Sudan and Zambia. Human Resources for Health, 7, 78.
Robinson, J. S., Burkhalter, B. R., Rasmussen, B., & Sugiono, R. (2001). Low-cost on-the-job peer training of nurses improved immunization coverage in Indonesia. Bulletin of the World Health Organization, 79(2), 150–158.